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Abstract. Golgi-endomannosidase provides an alter-
nate glucosidase-independent pathway of glucose
trimming. Activity for endomannosidase is detectable
in various tissues and cell lines but not in CHO cells.
Cloning of CHO cell endomannosidase revealed that
the highly conserved Trp188 andArg177 of vertebrate
endomannosidase were both substituted by Cys. The
Trp188Cys substitution was functionally important
since it alone resulted in endoplasmic reticulum (ER)
mislocalization of endomannosidase and caused the
greatly reduced in vivo activity. These effects could be
reversed in cells with a back-engineered Cys188Trp
CHO cell endomannosidase, in particular N-glycans
of a1-antitrypsin became fully processed. The intra-
molecular disulfide bridge of CHO cell endomanno-
sidase formed with the additional Cys188 was not
solely responsible for the reduced enzyme activity
since endomannosidase with engineered Cys188Ala
or Ser substitutions did not restore enzyme activity
and was ERmislocalized. Thus, the conserved Trp188
residue in endomannosidases is of critical importance
for correct subcellular localization and in vivo activity
of the enzyme.
Keywords. Endomannosidase, Golgi apparatus, endoplasmic reticulum, N-glycosylation, a1-antitrypsin, CHO
Lec 23 cells.
Introduction
Removal of glucose residues from asparagine-linked
Glc3Man9GlcNAc2 oligosaccharides by trimming glu-
cosidase I and II represents an important initial post-
translational modification of N-glycans. It starts the
pathway for further trimming and elongation reac-
tions in the endoplasmic reticulum (ER) and subse-
quently in the Golgi apparatus yielding the spectrum
of mature N-glycans [1, 2]. Glucose trimming by
glucosidase II has an additional aspect since it is of
importance for quality control of glycoprotein folding.
Here, glucosidase II-mediated de-glucosylation per-
mits the exit of glycoproteins from the calnexin/
calreticulin cycle [3–5].
An alternate glucosidase-independent pathway of
glucose trimming by endo-a-endomannosidase was
discovered by Spiro and colleagues [6, 7]. In contrast
to the ER-resident glucosidase II [8, 9], endomanno-
sidase is primarily located in the cis and medial Golgi
apparatus [9]. It is a unique endoglycosidase and
cleaves the a1,2 linkage between the glucose-substi-
tuted mannose and the remainder mannose branch of
N-glycans. The resulting Man8GlcNAc2 A-isomer is
no longer a substrate for UDP-Glc:glycoprotein
glucosyltransferase, but can be processed by Golgi-
mannosidase I [2, 10, 11]. Endomannosidase carries* Corresponding author.
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out a substantial amount of de-glucosylation in vivo, as
demonstrated by the processing of glycoproteins in
HepG2 cells [12]. Furthermore, the occurrence of a
Glc3Man tetrasaccharide in the urine of patientswith a
human congenital disorder of glycosylation caused by
glucosidase I deficiency might be an indication of the
action of endomannosidase [13]. Besides mono-glu-
cosylated oligosaccharides, di- and tri-glucosylated
oligosaccharides are also processed by endomannosi-
dase [6, 14, 15]. The latter two oligosaccharides
typically occur in glucosidase II-deficient Phar2.7
cells [16] or in glucosidase I-deficientCHOLec23 cells
[17, 18], respectively. Endomannosidase also counter-
acts the effects of experimental glucosidase I and II
inhibition by castanospermine [19, 20]. Thus, by
circumventing either a glucosidase deficiency or
inhibition, endomannosidase permits the formation
of mature, complex type N-glycans. As recently
demonstrated, glucosylated oligosaccharides of both
wild-type and of misfolded variants of a1-antitrypsin
are processed by endomannosidase [21]. This indi-
cates that the Golgi-localized endomannosidase pro-
vides a back-up mechanism for de-glucosylation of
ER-escaped native and misfolded glycoproteins al-
lowing the processing of their N-glycans to mature
ones.
Endomannosidase activity is detectable in vertebrates
tissues and in a range of animal and human cell lines
[9, 15, 22, 23]. However, CHO and CHO Lec23 cells
seem to be endomannosidase deficient. This is based
on the lack of measurable enzyme activity by sensitive
in vitro assays, the lack of generation of oligomannosyl
N-glycans from labeled tri-glucosyl oligosaccharides
in vivo, and the inability to process oligosaccharides of
the VSV G protein to mature ones in vivo when
glucosidase I and II were inhibited by castanosper-
mine [24, 25]. Nevertheless, evidence for some
residual endomannosidase activity in CHO and
CHO Lec23 cells has been obtained recently. In
CHOLec23 cells, which are deficient for glucosidase I
activity, structural analysis revealed presence of some
complex N-glycans [17]. Furthermore, in these cells
polysialic acidwas demonstrated on a small fraction of
N-CAM, which requires the previous synthesis of
complexN-glycans [17]. In our recent studies [21], we
also observed some processing of N-glycans of wild-
type and of Z-variant of a1-antitrypsin stably ex-
pressed inCHOcells under castanospermine-imposed
glucosidase blockade.
We report here the cloning of endomannosidase from
CHO cells and establish a molecular basis for the
endomannosidase deficiency in CHO cells. We find
that the highly conserved Arg177 and Trp188 are both
substituted by Cys in CHO cell endomannosidase.
However, only the Trp188Cys substitution in CHO
endomannosidase results in its mislocalization to the
ER and greatly reduced in vivo activity.
Materials and methods
Reagents and antibodies. Polyclonal rabbit anti-rat endomannosi-
dase antibody was kindly provided by Dr. R. G. Spiro (Boston,
MA) and rabbit anti-human Sec61b by Dr. B. Dobberstein
(Heidelberg, Germany). Rabbit anti-human a1-antitrypsin anti-
body was purchased from Dako (Zug, Switzerland), mouse
monoclonal anti-myc antibody from Upstate (Milton Keynes,
UK), rhodamine-conjugated (Fab’)2 fragments of goat anti-rabbit
IgG and Alexa 488-conjugated (Fab’)2 fragments of goat anti-
mouse IgG fromMolecular Probes (Eugene, OR) and horseradish
peroxidase-conjugated goat anti-rabbit IgG and goat anti-mouse
IgG from Jackson ImmunoResearch Laboratories, Inc. (West
Grove, PA).
Restriction enzymes, T4 DNA ligase, alkaline phosphatase,
endoglycosidase H (Endo H), recombinant N-glycosidase F
(PNGase F) and protease inhibitor tablets were purchased from
Roche Diagnostics (Rotkreuz, Switzerland), the reverse tran-
scription system from Promega (Wallisellen, Switzerland), Taq
DNA polymerase, expression vectors pcDNA3.1 and pcDNA6/
myc-His, pGEM-T easy vector, competent E. coli DH5a cells,
Lipofectamine 2000, cell culture media and fetal bovine serum
from Invitrogen (Basel, Switzerland), TRI reagent from Lucerna
Chem (Luzern, Switzerland), SMARTRACEcDNAamplification
Kit fromBDBiosciences (Basel, Switzerland) andQIAquickPCR-
purification Kit from QIAGEN (Basel, Switzerland). Oligonu-
cleotides were synthesized by Microsynth (Balgach, Switzerland).
[35S]Methionine/cysteine was purchased from Anawa Trading SA
(Wangen, Switzerland) and protein A magnetic beads from Dynal
(Hamburg, Germany).
Cell lines and transfections. The CHO Lec 23 cells [17, 18] were
kindly provided by Dr. Pamela Stanley (New York, NY) and
cultured in minimal essential medium Eagle (alpha modification)
containing 10% fetal bovine serum (FBS). CHO-K1 cells were
obtained fromAmerican Type Culture Collection (Manassas, VA)
and cultured in Hams F12 medium supplemented with 10% FBS.
Transfections of CHO Lec23 cells with the pcDNA3.1/a1-anti-
trypsin and the pcDNA6/endomannosidase constructs were per-
formed using Lipofectamine 2000 according to the manufacturers
instructions. For selection, cells were grown in medium containing
G418 (1 mg/ml) and Blasticidin (10 mg/ml). Clonal cell lines were
established in 96-multiwell plates and individual clones were tested
for expression of a1-antitrypsin and endomannosidase by immu-
nofluorescence and by RT-PCR.
Cloning of endomannosidase from CHO-K1 cells. Total RNA
from CHO-K1 cells was isolated, reverse transcribed and used
in the subsequent PCR amplification with the follow-
ACHTUNGTRENNUNGing rat endomannosidase [15] primers : ratEndo (sense) 5’-
GCCAAGAACTATCCCCAAGG-3’; ratEndo (antisense) 5’-
CTGTTCCGGGTGTTCTGAGT-3’. The missing 5’ and 3’ end of
the cDNA encoding CHO endomannosidase was isolated with a 5’
and a 3’ RACE procedure, respectively, according to the manu-
facturers instructions. The full-length CHOendomannosidase was
amplified by PCR using a sense primer (P1) containing a Hind III
site and the Kozak sequence 5’-AAAAGCTTATCATGG-
CAAAATTTCGAAGA-3’ and an antisense primer (P2) contain-
ing a Xho I site 5’-AACTCGAGTGAAGTAGGCAGCTGTT-
GAT-3’. The amplicon was subcloned into theHind III/Xho I sites
of the expression vector pcDNA6/myc-His, in frame with the C-
terminal myc- and His-tag.
Site-directed mutagenesis in CHO cell endomannosidase and rat
endomannosidase. All mutant CHO and rat endomannosidase were
generated by a PCR-based site-directed mutagenesis strategy. Briefly,
full-length CHO endomannosidase cDNA served as template in
combination with the CHO endomannosidase Cys177Arg antisense
primer which contained a Sca I site, (5’-GGGCCAGTACTCCAATT-
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GAGGCTGAGCGCATTTGTCTC-3) and the P1 primer (see
above) as well as the CHOendomannosidase Cys188Trp sense primer
with a Sca I site, (5’-ATTGGAGTACTGGCCCTTTCTTGG-
TACCCGCCTGA-3’) together with the P2 primer, respectively.
The PCR-product containing the specific mutation was subcloned
into the pcDNA6/CHO endomannosidase constructs, replacing the
wild-type sequence. The same strategy was applied for the gener-
ation of CHO endomannosidase Cys188Ser (5’-ATTGGAG-
TACTGGCCCTTTCTTCCTACCCGCCTGA-3’) and for Cys-
ACHTUNGTRENNUNG188Ala CHO endomannosidase (5’-ATTGGAGTACTGGCC-
ACHTUNGTRENNUNG TTTCTGCCTACCCGCCTGA-3’) in combination with primer
P2. For the CHO endomannosidase DCys177,188, the Sca I/Xho I
fragment of CHO endomannosidase Cys188Trp was subcloned into
CHO endomannosidase Cys177Arg replacing the corresponding
wild-type sequence. The Trp188Cys rat endomannosidase was
generated using the following primer: 5’-ATTGGAG-
TACTGGCCCTGTCTTGCTACCCACCTGA-3 in combination
with a 3-rat endomannosidase-specific antisense primer containing
a Xho I restriction site.
Endomannosidase hybrid constructs. For the rat/CHO endoman-
nosidase hybrid construct I, full-length rat endomannosidase in
pcDNA6/myc-His vector [21] was digested with Sca I/Xho I. The
~900-bp fragment was replaced by the corresponding Sca I/Xho I
fragment fromCHOendomannosidase. The reverse procedurewas
applied for the CHO/rat endomannosidase hybrid construct. For
the rat/CHOendomannosidase hybrid II construct, theNco I/Xho I
fragment of rat endomannosidase was replaced by the correspond-
ing one from CHO endomannosidase.
In vivo endomannosidase assay. Endomannosidase activity was
determined on the basis of the processing of the oligosaccharides of
human a1-antitrypsin. Glucosidase I-deficient CHO Lec23 cells
expressing human a1-antitrypsin and myc-tagged endomannosi-
dase constructs were metabolically labeled with [35S]methionine
for 20 min and chased for different time periods. Cell lysates (IC)
and culture medium (EC) were immunoprecipitated with anti-
human a1-antitrypsin antibody and the immunoprecipitates sub-
jected to digestion by Endo H (1U) or PNGase F (1U) for 16 h at
378C prior to 8% SDS-PAGE/fluorography as previously descri-
bed [21]. Radioactivity was visualized by fluorography after
treatment with EN3HANCER using X-Omatic AR film or
phosphorimager (FUJI Film Corp., Japan).
Combined immunoprecipitations and Western blotting. For im-
munoprecipitation, microsomal extracts [21] from CHO Lec23
cells, expressing either myc-tagged rat or CHO endomannosidase
were incubated overnight with anti-endomannosidase antibody
magnetic beads at 48C. For Western blot analysis, immunopreci-
pitates or microsomal extracts were separated in 8% SDS-
polyacrylamide gels (20 mg protein/lane), and transferred onto
nitrocellulose membranes using a semidry blotting apparatus [26].
The membranes were incubated with 0.4 mg/ml mouse monoclonal
anti-myc antibody overnight at 48C, followed by incubation with
the corresponding horseradish peroxidase-conjugated secondary
antibody.
For non-reducing conditions, microsomal extracts were heated for
5 min at 1008C in non-reducing sample buffer (100 mM Tris-HCl
pH 6.8, 4% SDS, 0.2% bromophenol blue), and analyzed by SDS-
PAGE on an 8% polyacrylamide gel. Western blot analysis was
performed as described above.
Confocal immunofluorescence microscopy. CHO Lec23 cells
stably expressing myc-tagged endomannosidase were formalde-
hyde-fixed and saponin-permeabilized as described [21]. For
double immunofluorescence, cells were simultaneously incubated
with monoclonal anti-myc antibody (4 mg/ml) or either anti-Golgi
mannosidase II or anti-Sec61b antibodies for 2 h at ambient
temperature, and washed three times with PBS containing 1%
BSA, followed by incubation with the appropriate fluorescent
secondary antibodies for 1 h. After rinses in buffer and double
distilled water, coverslips were embedded in Moviol.
Results
Isolation of full-length cDNA encoding CHO cell
endomannosidase. We have isolated and character-
ized the cDNA encoding endomannosidase from
CHO cells using a cDNA template from CHO cells
in combination with rat endomannosidase oligonu-
cleotide primers. An amplified RT-PCR fragment of
~700 bp exhibited high homology to endomannosi-
dase of rat (GenBank accession number: AF023657),
mouse (GenBank accession number: NM_172865),
human (GenBank accession number: BX640869) and
Xenopus laevis (GenBank accession number:
BC077304). Two additional PCR products of
~1000 bp and ~2600 bp were isolated by 5 and 3
RACE, which also showed high homology to known
endomannosidases. With the three independent PCR
products, the 3261-bp full-length cDNA encoding
CHO endomannosidase could be constructed. The
open reading frame encoded a 462-amino acid protein
of 53 223 Da (Fig. 1), which was in agreement with
deposited endomannosidase amino acid sequences
from mouse, rat and human. The hydrophobicity
profile [27] showed a stretch of 16 hydrophobic amino
acids comprising the residues 10–25 at the N terminus
(Fig. 1). The putative CHO cell endomannosidase
exhibited striking sequence identity to rat (88%),
mouse (88%), human (86%) and Xenopus laevis
(65%) endomannosidase (Fig. 1). No significant pri-
mary sequence homology to other known proteins
existed. Supporting evidence for authenticity of the
cloned cDNA was obtained by combined immuno-
precipitation/Western blot analysis of myc-tagged
CHO cell and rat endomannosidase expressed in
CHO Lec23 cells (Fig. 2). The ER-retained CHO cell
endomannosidase was synthesized as a 53-kDa pro-
tein. However, Golgi-localized rat endomannosidase
existed as a 58- and a 61-kDa species probably due to
Golgi-associated post-translational modifications
(Figs. 2 and 3a).
The highly conserved Arg177 and Trp188 are sub-
stituted by Cys in CHO cell endomannosidase.
Despite the striking sequence identity of the putative
CHO cell endomannosidase with the other cloned
endomannosidases, discrete amino acid substitutions
were observed. Noteworthy, the highly conserved
Arg177 and Trp188 were each substituted for Cys in
CHO cell endomannosidase (Fig. 1). Other highly
conserved residues such as Cys9 and 345 as well as
Met23 and 24 were preserved in CHO cell endoman-
nosidase (Fig. 1). A characteristic of the rat, mouse,
human and Xenopus laevis endomannosidase are
three consecutive Arg residues near the N terminus.
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Figure 1. The conserved Arg177 and Trp188 are substituted by Cys in CHO cell endomannosidase. The deduced amino acid sequence of
CHO cell endomannosidase (GenBankTM accession number DQ825405) is compared with mouse endomannosidase (accession number
NM_172865), rat endomannosidase (accession numberAF023657), human endomannosidase (accession numberBX640869) andXenopus
laevis endomannosidase (accession number BC077304). Amino acids conserved in all five species are highlighted and the Cys substitution
of the conserved Arg177 as well as Trp188 is marked by an asterisk. The bar above the amino acid sequence corresponds to a hydrophobic
region as deduced from the Kyte-Doolittle hydropathy plot [27].
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In CHO cell endomannosidase, two Arg residues and
one Lys were found in this position.
The presence of the two additional Cys residues in
CHO endomannosidase resulted in intramolecular
disulfide bridge formation as indicated by differential
migration behavior under reducing (Fig. 3a) and non-
reducing (Fig. 3b) conditions. This was not observed
for rat endomannosidase (Fig. 3a, b).
Trp188 is critical for Golgi localization and in vivo
activity of endomannosidase. The effect of the intra-
molecular disulfide bridge in CHO cell endomannosi-
dase on its subcellular distribution was analyzed by
double confocal immunofluorescence. Myc-tagged rat
endomannosidase expressed in CHO Lec23 cells
served as a control and showed the known Golgi
localization [9] as indicated by its co-distribution with
Golgi mannosidase II (Fig. 4a–c). In contrast, myc-
tagged CHO cell endomannosidase did not overlap
with Golgi mannosidase II, but with the ER-marker
Sec61b (Fig. 4d–f). Likewise, engineered Cys177Arg/
Cys188 CHO cell endomannosidase showed an ER
pattern (Fig. 4 g–i). However, engineered Cys177/
Cys188Trp as well as Cys177Arg/Cys188Trp CHO cell
endomannosidase exhibited Golgi localization as dem-
onstrated by the overlap with immunofluorescence for
Golgi mannosidase II (Fig. 4j–o). An ER localization
was also observed for an engineeredCys177/Cys188Ser
(Fig. 4p–r) and a Cys177/Cys188Ala (data not shown)
CHO cell endomannosidase. Among the studied CHO
cell/rat endomannosidase hybrid proteins, a Golgi
localization was only observed when the rat sequence
contained the Trp188 (data not shown). Furthermore,
replacement of the conserved Trp188 by Cys in rat
endomannosidase also resulted in ER localization
(data not shown). The subcellular localization of the
various endomannosidase constructs is given in
Table 1.
In CHO Lec23 cells, oligosaccharides remain in an
EndoH-sensitive, tri-glucosylated formbecause of the
glucosidase I deficiency [17, 18]. Therefore, this cell
line provides a suitable test system to study in vivo
activity of endomannosidase. For this purpose, we
established CHOLec23 cells stably expressing human
a1-antitrypsin and either myc-tagged CHO cell endo-
mannosidase or rat endomannosidase. In addition,
back-mutagenized CHO cell endomannosidase as
well as different CHO cell/rat endomannosidase
hybrid constructs were stably expressed. The acquis-
ition of EndoH resistance and of PNGase F sensitivity
of the oligosaccharides of a1-antitrypsin served as
criterion for in vivo activity of endomannosidase. In
glucosidase I-deficient CHO Lec23 cells, a1-antitryp-
sin was synthesized as an Endo H-sensitive 54-kDa
glycoprotein as expected (Fig. 5a). Endo H treatment
of secreted a1-antitrypsin resulted in one Endo H-
sensitive and one Endo H-resistant species, indicating
the presence of some residual endomannosidase
activity (Fig. 5a). Full processing of secreted a1-
antitrypsin N-glycans to Endo H-resistant and
PNGase F-sensitive ones was found in CHO Lec23
cells stably expressing rat endomannosidase (Fig. 5b).
The same effect was observed when back-engineered
Cys177Arg/Cys188Trp CHO cell endomannosidase
was stably expressed in CHO Lec23 cells (Fig. 5c).
In further experiments we sought to establish the
relative importance of the Trp188Cys and theArg177-
Cys substitution. In cells stably expressing Cys177/
Cys188Trp CHO cell endomannosidase, oligosacchar-
ides of a1-antitrypsin became fully processed
(Fig. 5d). The processing of the oligosaccharides of
a1-antitrypsin in cells expressing Cys177Arg/Cys188
CHOcell endomannosidase (Fig. 5e) was improved as
compared to ordinary CHO Lec23 cells (Fig. 5a). In
additional experiments, the effect of a Ser or Ala
substitution at Trp188 was evaluated. In CHO Lec23
cells, expressing CHO cell endomannosidase Cys177/
Figure 2. Expression of myc-tagged CHO cell or rat endomanno-
sidase inCHOLec23 cells. (a) ImmunoprecipitatedCHOcell or rat
endomannosidase was subjected to Western blot analysis using
anti-myc antibodies. The asterisk indicates position of immuno-
globulin heavy chain. (b) Western blot analysis of CHOLec 23 cell
extracts expressing myc-tagged CHO cell or rat endomannosidase.
Figure 3. CHO cell endomannosidase contains an intramolecular
disulfide bridge.Western blot analysis ofmyc-taggedCHOcell and
rat endomannosidase expressed in CHO Lec23 cells under
reducing conditions (a) and non-reducing conditions (b).
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Cys188Ser, the processing of a1-antitrypsin was
improved as compared to that of ordinary CHO
Lec23 cells (Fig. 5f), and the same was true, but to a
lesser extent, for cells expressing CHO cell endoman-
nosidase Cys177/Cys188Ala (Fig. 5 g). This effect was
also observed when endomannosidase hybrid con-
structs consisting of different portions of rat and CHO
cell endomannosidase were tested (data not shown).
The processing of the oligosaccharides of a1-antitryp-
sin in CHO Lec23 cells expressing Trp188Cys rat
endomannosidase was reduced (data not shown) as
compared to cells expressing rat endomannosidase
(Fig. 5b). All together, these data (see also Table 1)
indicate that the Trp188Cys substitution in CHO cell
endomannosidase or rat endomannosidase greatly
diminished its in vivo activity.
Figure 4. The conserved Trp188
in vertebrate endomannosidases
is important for Golgi localiza-
tion. Confocal double immuno-
fluorescence for myc-tagged en-
domannosidases expressed in
CHO Lec 23 cells and the Golgi
marker mannosidase II as well as
the ER marker Sec61b. Rat en-
domannosidase (a) and Golgi
mannosidase II (b) show co-dis-
tribution (c). In contrast, CHO
cell endomannosidase (d) or en-
gineered Cys177Arg/Cys188
CHO cell endomannosidase (g)
overlapwith Sec61b (e, f and h, i).
Golgi localization is restored in
engineered Cys177/Cys188Trp
(j–l) and in Cys177Arg/
Cys188Trp (m–o) CHO cell en-
domannosidase. Engineered
Cys177/Cys188Ser CHO cell en-
domannosidase remains ERmis-
localized (p–r). Bars 5 mm.
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Discussion
In the present study, we have established the molec-
ular basis for the endomannosidase deficiency inCHO
cells. The single Trp188Cys substitution had a dual
effect in that it resulted in the mislocalization of
endomannosidase into the ER and in greatly reduced
in vivo activity. Engineering and expression of a full-
length CHO cell endomannosidase cDNA into
Cys188Trp rescued the dual effect. Thus, the highly
conserved Trp188 residue of vertebrate endomanno-
sidases seems to be of critical importance for correct
subcellular localization and in vivo activity.
AlthoughCys substitutions were found at position 177
and 188 in CHO cell endomannosidase, replacing the
highly conserved Arg and Trp, only the Trp188Cys
substitution appears to be functionally of relevance.
This substitution resulted in intramolecular disulfide
bridge formation most probably leading to a confor-
mational change, whichmight account for the reduced
enzyme activity.When theCys188was replaced by Ser
or by Ala, the enzymatic activity could not be fully
rescued. Thus, it is tempting to speculate that the
Trp188 might be part of the substrate-binding site
forming hydrogen bonds with the glucosylated oligo-
saccharides [6, 14, 15]. Alternatively, the Trp188might
participate in the stabilization of the tertiary structure
at the active site or in the vicinity of the substrate-
binding site and in that way involved in maintaining
the enzymatic activity. Some experimental evidence in
favor of the latter hypothesis was obtained since we
observed that the Cys188Ser CHO cell endomanno-
sidase possessed a higher processing efficiency for a1-
antitrypsin oligosaccharides than the Cys188Ala
CHO cell endomannosidase.
Table 1. Localization and in vivo activity of various endomannosidase constructs expressed in glucosidase I-deficient CHO Lec23 cells.
Constructa Localizationb In vivo activityc
Rat Endo-myc Golgi Full
CHO Endo-myc ER Residual
CHO Endo-myc Cys177Arg/Cys188 ER Partial
CHO Endo-myc Cys177/ Cys188Trp Golgi Full
CHO Endo-myc Cys177Arg/Cys188Trp Golgi Full
CHO Endo-myc Cys177/Cys188Ser ER Partial
CHO Endo-myc Cys177/Cys188Ala ER Partial
Rat/CHO endomannosidase hybrid I ER Partial
CHO/rat endomannosidase hybrid I Golgi Full
Rat/CHO endomannosidase hybrid II Golgi Full
Rat Endo-myc Trp188/Cys ER Partial
a The generation of the various endomannosiadase constructs is described in the Materials and methods.
b Localization of myc-tagged endomannosidases was performed by double confocal immunofluorescence using the Golgi marker
mannosidase II as well as the ER marker Sec61b.
c The acquisition of Endo H resistance of the oligosaccharides of a1-antitrypsin served as criterion for endomannosidase in vivo activity.
Figure 5. Engineered Cys188Trp CHO cell endomannosidase
compensates for the enzyme deficiency. Processing of immuno-
precipitated a1-antitrypsin by endomannosidase fromCHOLec23
cells was analyzed (for details see Material and methods). (a) In
control CHO Lec23 cells, the oligosaccharides of intracellular a1-
antitrypsin (IC) were Endo H and PNGase F sensitive. Limited
processing of oligosaccharides of secreted a1-antitrypsin has
occurred as indicated by partial Endo H resistance of secreted
a1-antitrypsin (EC). (b) In CHO Lec23 cells expressing rat
endomannosidase, oligosaccharides of intracellular a1-antitrypsin
(IC) were Endo H and PNGase F sensitive, whereas oligosacchar-
ides of secreted a1-antitrypsin (EC) were fully processed as
indicated byEndoH resistance andPNGaseF sensitivity. (c, d) The
CHO cell endomannosidase deficiency could be rescued by
expressing either engineered Cys188Trp/Cys177Arg (c) or
Cys177/Cys188Trp CHO cell endomannosidase (d) as demonstrat-
ed by the Endo H resistance and PNGase F sensitivity of secreted
a1-antitrypsin. (e–g) The endomannosidase deficiency could not,
however, be fully rescued by expressing engineered Cys177Arg/
Cys188 (e), Cys177/Cys188Ser (f) or Cys177/Cys188Ala (g) CHO
cell endomannosidase.
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A second consequence of the Trp188Cys substitution
in CHO cell endomannosidase relates to its subcel-
lular distribution. The observed formation of an
intramolecular disulfide bridge between the Cys188
and pre-existing Cys residues might result in a
conformational change. However, we obtained no
evidence for the formation of endomannosidase
aggregates. The mislocalization of CHO cell endo-
mannosidase into the ER unequivocally indicates that
the enzyme is transport incompetent and might be
recognized and retained by the protein quality control
[28].Although inactivating pointmutations have been
identified for other Golgi-localized enzymes such as
N-acetylglucosaminyltransferase I in CHO Lec1 cells
[29] and BHK cells [30] or N-acetylglucosaminyl-
transferaseVinCHOLec4 cells [31], these amino acid
substitutions did not affect the inherent Golgi local-
ization of these glycosyltransferases. Conversely, the
point mutation in the N-acetylglucosaminyltransfer-
ase V gene in CHO Lec4A cells resulted in a
mislocalized but active enzyme [31]. On the other
hand, a Cys residue, together with parts of the
transmembrane region and the cytosolic tail, has
been shown to be important for Golgi localization of
an a2,6 sialyltransferase exhibiting low catalytic
activity [32, 33]. Thus, several different mechanisms
occur to function together in the Golgi localization of
glycosyltransferases [34]. Although the mechanistic
aspects of the dual effect of theTrp188Cys substitution
in CHO cell endomannosidase remain to be elucidat-
ed, most probably it is a conformational change
caused by the intramolecular disulfide bridge, which
makes the endomannosidase a substrate for the
protein quality control. Point mutations resulting in
the formation of incorrectly folded proteins are well
established as the cause of many ER retention
diseases [35–38].
In summary, we elucidated the molecular defect in
CHO cell endomannosidase and demonstrated that
the Trp188Cys substitution profoundly affects the
subcellular localization and the in vivo activity of this
Golgi enzyme.
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